These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1669 related articles for article (PubMed ID: 33362788)

  • 1. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
    Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
    Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiota-Gut-Brain Axis.
    Cryan JF; O'Riordan KJ; Cowan CSM; Sandhu KV; Bastiaanssen TFS; Boehme M; Codagnone MG; Cussotto S; Fulling C; Golubeva AV; Guzzetta KE; Jaggar M; Long-Smith CM; Lyte JM; Martin JA; Molinero-Perez A; Moloney G; Morelli E; Morillas E; O'Connor R; Cruz-Pereira JS; Peterson VL; Rea K; Ritz NL; Sherwin E; Spichak S; Teichman EM; van de Wouw M; Ventura-Silva AP; Wallace-Fitzsimons SE; Hyland N; Clarke G; Dinan TG
    Physiol Rev; 2019 Oct; 99(4):1877-2013. PubMed ID: 31460832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the microbiota in pharmacology of psychiatric disorders.
    Pascale A; Marchesi N; Govoni S; Barbieri A
    Pharmacol Res; 2020 Jul; 157():104856. PubMed ID: 32389857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental neurotoxicants and inflammasome activation in Parkinson's disease - A focus on the gut-brain axis.
    Johnson AM; Ou ZA; Gordon R; Saminathan H
    Int J Biochem Cell Biol; 2022 Jan; 142():106113. PubMed ID: 34737076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
    Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing Gut Microbes for Mental Health: Getting From Here to There.
    Bruce-Keller AJ; Salbaum JM; Berthoud HR
    Biol Psychiatry; 2018 Feb; 83(3):214-223. PubMed ID: 29031410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota and its correlations with the central nervous system disorders.
    Catanzaro R; Anzalone M; Calabrese F; Milazzo M; Capuana M; Italia A; Occhipinti S; Marotta F
    Panminerva Med; 2015 Sep; 57(3):127-43. PubMed ID: 25390799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
    Spielman LJ; Gibson DL; Klegeris A
    Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Neurologic Diseases and Injuries.
    Tyler Patterson T; Grandhi R
    Adv Exp Med Biol; 2020; 1238():73-91. PubMed ID: 32323181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.
    Rogers GB; Keating DJ; Young RL; Wong ML; Licinio J; Wesselingh S
    Mol Psychiatry; 2016 Jun; 21(6):738-48. PubMed ID: 27090305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota-brain axis in neurological disorder.
    Ullah H; Arbab S; Tian Y; Liu CQ; Chen Y; Qijie L; Khan MIU; Hassan IU; Li K
    Front Neurosci; 2023; 17():1225875. PubMed ID: 37600019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced gut microbiome protects from alcohol-induced neuroinflammation and alters intestinal and brain inflammasome expression.
    Lowe PP; Gyongyosi B; Satishchandran A; Iracheta-Vellve A; Cho Y; Ambade A; Szabo G
    J Neuroinflammation; 2018 Oct; 15(1):298. PubMed ID: 30368255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.